| __timestamp | Iovance Biotherapeutics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 9335772 | 1802274 |
| Thursday, January 1, 2015 | 12390000 | 2512761 |
| Friday, January 1, 2016 | 25602000 | 2894488 |
| Sunday, January 1, 2017 | 21262000 | 8096274 |
| Monday, January 1, 2018 | 28430000 | 7985229 |
| Tuesday, January 1, 2019 | 40849000 | 8994597 |
| Wednesday, January 1, 2020 | 60210000 | 29772000 |
| Friday, January 1, 2021 | 83664000 | 33907000 |
| Saturday, January 1, 2022 | 104097000 | 26579000 |
| Sunday, January 1, 2023 | 106916000 | 49868547 |
Unleashing the power of data
In the dynamic world of biotechnology, understanding financial trends is crucial for investors and stakeholders. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two pioneering companies: Iovance Biotherapeutics, Inc. and Verona Pharma plc, from 2014 to 2023.
Iovance has shown a remarkable upward trajectory in SG&A expenses, growing by over 1,000% from 2014 to 2023. This increase reflects the company's aggressive expansion and investment in its innovative cancer therapies.
Verona Pharma, while smaller in scale, has also seen a significant rise in SG&A expenses, with a growth of approximately 2,700% over the same period. This surge underscores its commitment to advancing respiratory disease treatments.
Both companies exemplify the biotech sector's rapid growth, driven by innovation and strategic investments.
Novo Nordisk A/S or Verona Pharma plc: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Verona Pharma plc
Neurocrine Biosciences, Inc. and Iovance Biotherapeutics, Inc.: SG&A Spending Patterns Compared
Walgreens Boots Alliance, Inc. vs Verona Pharma plc: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Halozyme Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Verona Pharma plc and CymaBay Therapeutics, Inc.: SG&A Spending Patterns Compared
Verona Pharma plc or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Verona Pharma plc or Novavax, Inc.
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.
Mesoblast Limited or Iovance Biotherapeutics, Inc.: Who Manages SG&A Costs Better?